These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10611140)

  • 1. Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo.
    Pichard-Garcia L; Hyland R; Baulieu J; Fabre JM; Milton A; Maurel P
    Drug Metab Dispos; 2000 Jan; 28(1):51-7. PubMed ID: 10611140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eletriptan.
    Gawel MJ; Grujich NN
    Expert Opin Investig Drugs; 2001 Oct; 10(10):1869-74. PubMed ID: 11772292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the adrenal 11-beta-hydroxylase inhibitor metyrapone on human hepatic cytochrome P-450 expression: induction of cytochrome P-450 3A4.
    Harvey JL; Paine AJ; Maurel P; Wright MC
    Drug Metab Dispos; 2000 Jan; 28(1):96-101. PubMed ID: 10611146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up.
    Meunier V; Bourrié M; Julian B; Marti E; Guillou F; Berger Y; Fabre G
    Xenobiotica; 2000 Jun; 30(6):589-607. PubMed ID: 10923861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
    Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
    Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of induction of cytochrome P450 by NO-1886 (ibrolipim), a lipoprotein lipase-promoting agent, in primary cultures of human hepatocytes and in female rat liver.
    Morioka Y; Nishimura M; Imai T; Suzuki S; Harada M; Satoh T; Naito S
    Drug Metab Pharmacokinet; 2006 Feb; 21(1):19-28. PubMed ID: 16547390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine].
    Omote M
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):93-101. PubMed ID: 12843576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spotlight on eletriptan in migraine.
    McCormack PL; Keating GM
    CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review.
    Mathew NT; Hettiarachchi J; Alderman J
    Headache; 2003 Oct; 43(9):962-74. PubMed ID: 14511273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eletriptan: pharmacological differences and clinical results.
    Giffin N
    Curr Med Res Opin; 2001; 17 Suppl 1():s59-62. PubMed ID: 12463280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL; Keating GM
    Drugs; 2006; 66(8):1129-49. PubMed ID: 16789799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of human hepatocyte cultures to study the induction of cytochrome P-450.
    Kostrubsky VE; Ramachandran V; Venkataramanan R; Dorko K; Esplen JE; Zhang S; Sinclair JF; Wrighton SA; Strom SC
    Drug Metab Dispos; 1999 Aug; 27(8):887-94. PubMed ID: 10421615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism.
    Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M
    J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.
    Diener HC; Jansen JP; Reches A; Pascual J; Pitei D; Steiner TJ;
    Eur Neurol; 2002; 47(2):99-107. PubMed ID: 11844898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interactions with 17 alpha-ethynylestradiol.
    Olsen AK; Hansen KT; Friis C
    Chem Biol Interact; 1997 Nov; 107(1-2):93-108. PubMed ID: 9402952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
    Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
    Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
    Pichard L; Gillet G; Bonfils C; Domergue J; Thénot JP; Maurel P
    Drug Metab Dispos; 1995 Nov; 23(11):1253-62. PubMed ID: 8591727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,3'-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices.
    Lake BG; Tredger JM; Renwick AB; Barton PT; Price RJ
    Xenobiotica; 1998 Aug; 28(8):803-11. PubMed ID: 9741959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.
    Robertson P; DeCory HH; Madan A; Parkinson A
    Drug Metab Dispos; 2000 Jun; 28(6):664-71. PubMed ID: 10820139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.
    Johnson DE; Rollema H; Schmidt AW; McHarg AD
    Eur J Pharmacol; 2001 Aug; 425(3):203-10. PubMed ID: 11513839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.